08/09/2011 | Autor / Editor: Prasanta Kumar Chatterjee / Marion Henig
Prasanta Kumar Chatterjee: How is Sartorius addressing the need of the hour in this sub-continent?
Amit Chatterjee: Sartorius’ strategy and capabilities in being able to offer Integrated Solutions across the process chain of fermentation, cell cultivation, filtration, purification, fluid management and lab technologies help manufacturing companies and labs develop and produce drugs safely, timely and economically. With focus on single-use technologies and value-added services, we are able to support the need of the industry for flexibility and regulatory compliance, particularly important for multipurpose manufacturing facilities in India. Our process knowledge, technology and products basket are also aligned with the government’s initiative to ensure cGMP compliance of local vaccine production facilities. We not only serve the end-customers, but also partner with several OEMs in developing solutions for the critical needs of the Biopharma customers. Our philosophy of ensuring – that every product we launch must have true scalability both upwards and downwards – makes it easy for our customers to continuously invest into optimizing their current processes by using alternate or new technologies to further improve yields and reduce costs.
This article is protected by copyright. You want to use it for your own purpose? Infos can be found under www.mycontentfactory.de (ID: 28666500) | Fotos: Picture: PROCESS India